In vivo 31P magnetic resonance spectroscopy of the human liver at 7T: An initial experience

NMR in Biomedicine

Volumn 27, Issue 4, 2014, Pages 478-485

  Chmelik, Marek ^a   Považan, Michal ^a,b   Krššák, Martin ^a   Gruber, Stephan ^a   Tkačov, Martin ^a,b   Trattnig, Siegfried ^a   Bogner, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Physics and Informatics   (Slovakia)

Author keywords

7T; Human liver; Localization; Phosphorus; Relaxation; Spectroscopic imaging; Spectroscopy

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOMOLECULES; CRAMER-RAO BOUNDS; GLYCEROL; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; PHOSPHORUS; RELAXATION TIME; SPECTROSCOPY;

7T; HUMAN LIVER; LOCALIZATION; RELAXATION; SPECTROSCOPIC IMAGING;

THREE DIMENSIONAL;

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA ADENOSINE TRIPHOSPHATE; BETA ADENOSINE TRIPHOSPHATE; GAMMA ADENOSINE TRIPHOSPHATE; GLYCEROL 3 PHOSPHORYLETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHATE; PHOSPHATIDYLCHOLINE; PHOSPHOENOLPYRUVATE; PHOSPHOETHANOLAMINE; PHOSPHORIC ACID DERIVATIVE; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE;

ADULT; ARTICLE; FEASIBILITY STUDY; FEMALE; HEPATOGRAPHY; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; MALE; NORMAL HUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RELAXATION TIME; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

7 T; HUMAN LIVER; LOCALIZATION; PHOSPHORUS; RELAXATION; SPECTROSCOPIC IMAGING; SPECTROSCOPY; T1;

ADULT; ANIMALS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; PHOSPHORUS; RATS; TIME FACTORS;

EID: 84895930614     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3084     Document Type: Article

References (49)

1. Meyerhoff DJ, Boska MD, Thomas AM, Weiner MW. Alcoholic liver-disease - quantitative image-guided P-31 MR spectroscopy. Radiology 1989; 173(2): 393-400.
2. Voert EGW, Heijmen L, Laarhoven HWM, Heerschap A. In vivo magnetic resonance spectroscopy of liver tumors and metastases. World J. Gastroenterol. 2011; 17(47): 5133-5149.
3. Schmid AI, Chmelik M, Szendroedi J, Krssak M, Brehm A, Moser E, Roden M. Quantitative ATP synthesis in human liver measured by localized P-31 spectroscopy using the magnetization transfer experiment. NMR Biomed. 2008; 21(5): 437-443.
4. Schmid AI, Szendroedi J, Chmelik M, Krssak M, Moser E, Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 2011; 34(2): 448-453.
5. Sevastianova K, Hakkarainen A, Kotronen A, Corner A, Arkkila P, Arola J, Westerbacka J, Bergholm R, Lundbom J, Lundbom N, Yki-Jarvinen H. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T (31)P MR spectroscopy with proton decoupling. Radiology 2010; 256(2): 466-473.
6. 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed. 2011; 24(3): 231-237.
7. Noren B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O. Absolute quantification of human liver metabolite concentrations by localized in vivo P-31 NMR spectroscopy in diffuse liver disease. Eur. Radiol. 2005; 15(1): 148-157.
8. Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo YT, Goldin RD, Taylor-Robinson SD. P-31 MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. Am. J. Roentgenol. 2007; 189(4): 819-823.
9. Cox IJ, Sargentoni J, Calam J, Bryant DJ, Iles RA. Four-dimensional phosphorus-31 chemical shift imaging of carcinoid metastases in the liver. NMR Biomed. 1988; 1(1): 56-60.
10. Cox IJ, Bell JD, Peden CJ, Iles RA, Foster CS, Watanapa P, Williamson RC. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. NMR Biomed. 1992; 5(3): 114-120.
11. 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997; 17(4): 198-209.
12. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995; 21(2): 417-427.
13. Changani KK, Jalan R, Cox IJ, Ala-Korpela M, Bhakoo K, Taylor-Robinson SD, Bell JD. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001; 49(4): 557-564.
14. Taylor-Robinson SD, Sargentoni J, Bell JD, Thomas EL, Marcus CD, Changani KK, Saeed N, Hodgson HJ, Davidson BR, Burroughs AK, Rolles K, Foster CS, Cox IJ. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 1998; 42(5): 735-743.
15. Dagnelie PC, Menon DK, Cox IJ, Bell JD, Sargentoni J, Coutts GA, Urenjak J, Iles RA. Effect of L-alanine infusion on 31P nuclear magnetic resonance spectra of normal human liver: towards biochemical pathology in vivo. Clin. Sci. 1992; 83(2): 183-190.
16. Dagnelie PC, Bell JD, Cox IJ, Menon DK, Sargentoni J, Coutts GA, Williams SC. Effects of fish oil on phospholipid metabolism in human and rat liver studied by 31P NMR spectroscopy in vivo and in vitro. NMR Biomed. 1993; 6(2): 157-162.
17. Iles RA, Cox IJ, Bell JD, Dubowitz LM, Cowan F, Bryant DJ. 31P magnetic resonance spectroscopy of the human paediatric liver. NMR Biomed. 1990; 3(2): 90-94.
18. 31P magnetic resonance spectroscopy. Liver Int. 2008; 28(5): 675-681.
19. 31P metabolites in human liver. Magn. Reson. Med. 2008; 60(4): 796-802.
20. Meyerhoff DJ, Karczmar GS, Matson GB, Boska MD, Weiner MW. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy. NMR Biomed. 1990; 3(1): 17-22.
21. 31P relaxation times in the human calf muscle: a comparison between 3T and 7T in vivo. Magn. Reson. Med. 2009; 62(3): 574-582.
22. 31P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3T and 7T. Magn. Reson. Med. 2011; 66(4): 923-930.
23. Lei H, Zhu XH, Zhang XL, Ugurbil K, Chen W. In vivo P-31 magnetic resonance spectroscopy of human brain at 7T: an initial experience. Magn. Reson. Med. 2003; 49(2): 199-205.
24. Qiao H, Zhang XL, Zhu XH, Du F, Chen W. In vivo 31P MRS of human brain at high/ultrahigh fields: a quantitative comparison of NMR detection sensitivity and spectral resolution between 4T and 7T. Magn. Reson. Imaging 2006; 24(10): 1281-1286.
25. 31P MRS detection of an alkaline inorganic phosphate pool with short T1 in human resting skeletal muscle. NMR Biomed. 2010; 23(8): 995-1000.
26. 1H MRS at 7T: initial results in human breast cancer. NMR Biomed. 2011; 24(10): 1337-1342.
27. Bell JD, Bhakoo KK. Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed. 1998; 11(7): 354-359.
28. Boesch C, Elsing C, Wegmuller H, Felblinger J, Vock P, Reichen J. Effect of ethanol and fructose on liver metabolism: a dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers. Magn. Reson. Imaging 1997; 15(9): 1067-1077.
29. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. U. S. A. 1982; 79(11): 3523-3526.
30. 1H coil. Magn. Reson. Med. 2012; 68(5): 1346-1356.
31. Cox IJ, Bryant DJ, Collins AG, George P, Harman RR, Hall AS, Hodgson HJ, Khenia S, McArthur P, Spencer DH, Young IR. Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver. J. Comput. Assist. Tomogr. 1988; 12(3): 369-376.
32. Ordidge RJ, Connelly A, Lohman JAB. Image-Selected In Vivo Spectroscopy (ISIS) - a new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 1986; 66(2): 283-294.
33. Evelhoch JL, Ewy CS, Siegfried BA, Ackerman JJ, Rice DW, Briggs RW. 31P spin-lattice relaxation times and resonance linewidths of rat tissue in vivo: dependence upon the static magnetic field strength. Magn. Reson. Med. 1985; 2(4): 410-417.
34. Li CW, Negendank WG, MurphyBoesch J, PadavicShaller K, Brown TR. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced P-31 NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed. 1996; 9(4): 141-155.
35. Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen AG. Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J. Magn. Reson. 2010; 203(2): 283-293.
36. Chmelik M, Just Kukurova I, Gruber S, Krssak M, Valkovic L, Trattnig S, Bogner W. Fully adiabatic (31)P 2D-CSI with reduced chemical shift displacement error at 7T - GOIA-1D-ISIS/2D-CSI. Magn. Reson. Med. 2012. DOI: 10.1002/mrm.24363.
37. Kupce E, Freeman R. Adiabatic pulses for wide-band inversion and broad-band decoupling. J. Magn. Reson. A 1995; 115(2): 273-276.
38. Vanhamme L, den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 1997; 129(1): 35-43.
39. Stefan D, Di Cesare F, Andrasescu A, Popa E, Lazariev A, Vescovo E, Strbak O, Williams S, Starcuk Z, Cabanas M, Ormondt D, Graveron-Demilly D. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas. Sci. Technol. 2009; 20(10). DOI: 10.1088/0957-0233/20/10/104035.
40. 31P MRS: a quantitative review. NMR Biomed. 2007; 20(6): 555-565.
41. Bates TE, Williams SR, Gadian DG. Phosphodiesters in the liver: the effect of field strength on the 31P signal. Magn. Reson. Med. 1989; 12(1): 145-150.
42. Murphy EJ, Bates TE, Williams SR, Watson T, Brindle KM, Rajagopalan B, Radda GK. Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths. Biochim. Biophys. Acta 1992; 1111(1): 51-58.
43. Ijare O, Bezabeh T, Albiin N, Bergquist A, Arnelo U, Lohr M, Smith I. Potential of 31P magnetic resonance spectroscopy of bile in the detection of cholestatic diseases. Proceedings of the 19th Annual Meeting ISMRM, Montreal, Canada, 2011, 1002.
44. Small DM, Bourges M, Dervichian DG. Ternary and quaternary aqueous systems containing bile salt, lecithin, and cholesterol. Nature 1966; 211(5051): 816-818.
45. Bottomley P, Foster T, Darrow R. Depth-resolved surface-coil spectroscopy (DRESS) for in vivo 1H, 31P, and 13C NMR. J. Magn. Reson. 1984(59): 338-342.
46. Devre RM, Maerschalk C, Delporte C. Spin-lattice relaxation-times and nuclear Overhauser enhancement effect for P-31 metabolites in model solutions at 2 frequencies - implications for in vivo spectroscopy. Magn. Reson. Imaging 1990; 8: 691-698.
47. 1 measurement in-vivo with low-angle adiabatic pulses. J. Magn. Reson. B 1994; 104(2): 159-167.
48. 1 values of phosphorus metabolites in human liver and muscle determined at 1.5T by chemical shift imaging. NMR Biomed. 1989; 2(5/6): 298-304.
49. Pohmann R, von Kienlin M. Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn. Reson. Med. 2001; 45(5): 817-826.